Hyloris Pharmaceuticals SA HYL-BE:Euronext Brussels

*Data is delayed | EUR
Last | 1:03 PM CEST
13.60quote price arrow down-0.20 (-1.45%)
Volume
4,443
52 week range
8.80 - 14.50

...

Loading . . .
  • Open13.65
  • Day High13.70
  • Day Low13.50
  • Prev Close13.80
  • 52 Week High14.50
  • 52 Week High Date05/31/21
  • 52 Week Low8.80
  • 52 Week Low Date08/27/20

Key Stats

  • Market Cap412.88M
  • Shares Out25.59M
  • 10 Day Average Volume5,355.5
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change43.16

KEY STATS

  • Open13.65
  • Day High13.70
  • Day Low13.50
  • Prev Close13.80
  • 52 Week High14.50
  • 52 Week High Date05/31/21
  • 52 Week Low8.80
  • 52 Week Low Date08/27/20
  • Market Cap412.88M
  • Shares Out25.59M
  • 10 Day Average Volume5,355.5
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change43.16

RATIOS/PROFITABILITY

  • EPS (TTM)-1.23
  • P/E (TTM)-11.09
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Hyloris Pharmaceuticals SA

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Hyloris Pharmaceuticals is a Belgium-based specialty pharmaceutical company. Its focus is on re-engineering cardiovascular products. Additionally, it also further develops and improves already-approved pharmaceuticals and established products, creating new and different solutions. The Company’s diverse product-development portfolio spans a wide range of therapeutic indications and dosage forms.
Address
Boulevard Gustave Kleyer 17
Liege
4000
Belgium